Featured Content

Articles

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically, Liora has created the LiGHT System, which is believed to provide many advantages over other proton therapy methods and systems that are currently available. While it … Continue reading “Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy”

TinyGemsBreaks

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline 

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, which is pioneering proton therapy systems for treating tumors in various types of cancers. “Liora is becoming a wholly owned subsidiary of LIXTE, and the acquisition also includes Liora’s proprietary flagship technology, the LiGHT System (Linac for Image Guided Hadron Therapy), which offers many advantages over other technologies … Continue reading “TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline “

Sector News

Filter Releases
Sectors



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}

NewsRoom

Receive Alerts from TinyGems

Text "Gems" to 888-902-4192

(US Mobile Phones Only)

About TinyGems

Discover diamonds in the rough with TinyGems.

TinyGems spotlights emergent small-cap companies with bright futures and big potential. Small and yet unproven, there’s obvious risk but also huge upside possibilities for investors in the know. Contrary to conventional dogma, shares of small-cap and mid-cap companies posted far superior total returns than mega-cap stocks since December 1999.

Don’t overlook the innovation of disruptive small-cap companies on the cusp of market discovery. TinyGems puts a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios.

More About TinyGems    Schedule a Live Online Demo

Contact us: (512) 354-7000